Shawn Elms

Director of Field Medical Affairs at Braeburn

Shawn Elms has a comprehensive work experience, showcasing proficiency in medical science liaison and research roles. Shawn is currently serving as the Director of Field Medical Affairs at Braeburn. Before that, they worked at Biogen as a Senior Medical Science Liaison from March 2020 to November 2022. Prior to Biogen, they were employed at Teva Pharmaceuticals, where they held the positions of Senior Medical Science Liaison and Medical Science Liaison. During their time at Teva Pharmaceuticals, they launched a novel therapy and worked in various medical fields, including behavioral health, emergency medicine, oncology, multiple sclerosis, and migraine.

Earlier in their career, they worked as a Post-Doctoral Fellow at Emory University School of Medicine, focusing on miRNA-mediated changes in the vascularity of atherosclerotic mice. Shawn also holds experience as a PhD Student at the Medical College of Georgia at Augusta University, where they conducted research on arginase, endothelial function, diabetic retinopathy, and retinal vasculature. Additionally, Shawn worked as a Research Assistant in the Laboratory of Roy Sutliff at Emory University, specializing in pulmonary dysfunction related to HIV infection.

Overall, Shawn Elms has a diverse background in medical research and liaison roles, making him a valuable asset in the field.

Shawn Elms completed a PhD in Vascular Biology from the Medical College of Georgia at Augusta University from 2006 to 2011. Prior to that, from 1994 to 1998, they obtained a BS degree in Biology and Philosophy from Wofford College.

Location

Atlanta, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Braeburn

Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. They are committed to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare professionals, payers and society.


Industries

Employees

11-50

Links